Revenue
attach_money178M USD
YoY +195.3%
ADAPYAdaptimmune Therapeutics plc$ --
Adaptimmune Therapeutics plc
ADAPY
$ -
-
You can review earnings summary, quarterly trends, full-year progress, and detailed income statement data.
analyticsIncome Statement Summary
FY2024 Full YearUpdated: 12/31/2024
Operating Income
bar_chart-69M USD
YoY +50.2%
Net Income
verified-71M USD
YoY +37.8%
EPS
pie_chart-0.28USD
YoY +50.9%
Quarterly Performance
Quarterly revenue and net income trend
RevenueOperating IncomeNet Income
No quarterly data available
Full-Year Progress
Net Income Progress386.1%On Track
Revenue Progress21M
Revenue Forecast27.4M
Net Income Progress-77.9M
Net Income Forecast-20.2M
Income Statement Details
Item
Revenue
Cost of revenue
Gross profit
Research & development
Selling & marketing
Selling, general and administrative
Other operating expenses
Operating income
Interest expense
Income before tax
Income tax expense
Net income
Unlock Long-Term Income Statement Data
Your current plan allows viewing financial data for the latest 1 year (annual only). Upgrade to the Standard Plan to view up to 3 years (including quarterly data), or the Premium Plan to access all historical data.